NIH-funded research R01 grant

Exploring how therapies and medications affect youth with Autism Spectrum Disorders

Official title: The interplay of behavioral therapies, pharmacological treatments and psychiatric adverse events among Youth with Autism Spectrum Disorders

Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11056764 · Data updated 2026-11-12

This study looks at how different therapies and medications help young people with Autism Spectrum Disorders, especially focusing on any side effects they might experience, while also considering how things like race, gender, and income can affect their treatment during tough times like the COVID-19 pandemic.

More Autism research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr
NIH-funded
Lab location1 site (Hershey, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2025
Award (this year)$386,704
NIH project number5R01HS029003-03
Project IDNIH-11056764 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are youth diagnosed with Autism Spectrum Disorders who may also be experiencing comorbid psychiatric conditions.

Less likely to help

Patients without a diagnosis of Autism Spectrum Disorders or those who do not have any comorbid psychiatric conditions may not benefit from this research.

What this research studies

This research investigates the effects of behavioral therapies and pharmacological treatments on youth with Autism Spectrum Disorders (ASD), particularly focusing on the psychiatric adverse events that may arise. It aims to understand how these treatments are utilized in real-world settings, considering the diverse needs of individuals with ASD and the impact of factors such as race, gender, and socioeconomic status. The study will analyze treatment patterns and the potential negative effects of polypharmacy on the effectiveness of behavioral therapies, especially in the context of increased stress due to the COVID-19 pandemic.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for youth with ASD, enhancing their overall health and well-being.

How similar studies have gone: While there is ongoing research in the area of ASD treatment, this study addresses specific gaps related to the interplay of therapies and medications, making it a novel approach.

Where this research is happening

  • Pennsylvania State Univ Hershey Med Ctr
    Hershey, United States
    Active

Researchers

  • Principal investigator: Liu, Guodong — Pennsylvania State Univ Hershey Med Ctr
  • Study coordinator: Liu, Guodong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.